Production (Stage)
Theratechnologies Inc.
TH.TO
TSX
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.92% | -23.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.92% | -23.82% | |||
| Cost of Revenue | 34.91% | -42.86% | |||
| Gross Profit | -16.28% | -17.68% | |||
| SG&A Expenses | 15.14% | 0.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.46% | -28.78% | |||
| Operating Income | -200.47% | 106.20% | |||
| Income Before Tax | -1,094.34% | 106.16% | |||
| Income Tax Expenses | -19.87% | -69.93% | |||
| Earnings from Continuing Operations | -3,913.68% | 101.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,913.68% | 101.48% | |||
| EBIT | -200.47% | 106.20% | |||
| EBITDA | -165.31% | 74.13% | |||
| EPS Basic | -3,866.67% | 101.50% | |||
| Normalized Basic EPS | -471.96% | 185.60% | |||
| EPS Diluted | -4,030.43% | 101.44% | |||
| Normalized Diluted EPS | -479.05% | 184.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -2.06% | 2.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||